LGND AI, Inc. | $9,000,000 | (Jul 11, 2025)
Cerebrium | $8,500,000 | (Jul 11, 2025)
Bilt | $250,000,000 | (Jul 11, 2025)
Certified by Founder
Lodge
XyloCor Therapeutics, Inc.
start up
United States
- King of Prussia, Pennsylvania
- 09/01/2025
- Series B
- $67,500,000
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
- Industry Research Services
- Website https://www.xylocor.com/
- LinkedIn https://www.linkedin.com/company/xylocor-therapeutics-inc./
Aqtual, Inc. | $31,000,000 | (Jul 11, 2025)
Knox Systems, Inc. | $6,500,000 | (Jul 11, 2025)
Live Story | $3,154,279 | (Jul 11, 2025)
Spacelift | $51,000,000 | (Jul 11, 2025)
Foundation EGI | $23,000,000 | (Jul 11, 2025)
Augmentus Robotics | $11,000,000 | (Jul 11, 2025)
Datafy.io | $20,000,000 | (Jul 11, 2025)
Renasant Bio | $54,500,000 | (Jul 11, 2025)
Supply Wisdom | $14,000,000 | (Jul 10, 2025)